Cheryl M. Coffin

Vanderbilt University — United States

Medicine · Health Sciences

60h-index15.1kcitations258works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(102), Soft tissue tumor case studies(65), Tumors and Oncological Cases(40), IgG4-Related and Inflammatory Diseases(35), Neuroendocrine Tumor Research Advances(32)

Publications258 total

Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
Pediatric Blood & Cancer·2024· 1 citedOpen Access
The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group Perspective
Archives of Pathology & Laboratory Medicine·2023· 8 citedOpen Access
Supplementary Figure 1 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure 2 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Methods from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 1 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure Legends, Table Legends from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Data from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 3 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 2 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 3 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 1 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure 2 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Table 2 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Data from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Methods from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure Legends, Table Legends from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure 1 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Data from Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group
2023Open Access
Data from Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Louis P. Dehner(12), Holly Zhou(6), Sherrie L. Perkins(5), Jason L. Hornick(4), Christopher D.�M. Fletcher(4), Rita Alaggio(4), Sheryl R. Tripp(3), Mario R. Capecchi(3), Margaret H. Collins(2), Melissa H. Cessna(2), Clark Daines(2), Charles Keller(2), David M. Parham(2), Sancy A. Leachman(2), Sharon W. Weiss(2), R. Lor Randall(2), Suzanne M. Yandow(2), David Viskochil(2), Mark D. Herron(2), Sheryll L. Vanderhooft(2)